Yunnun Druos Works · 66-41 · CHINA
For Yunnun Druos Works · 66-41 · CHINA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is CHINA; product is Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules; product code is 54 Y - - 04 Ginseng Unconventional Dietary Speciality for Humans or Animals | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 61 X - - 08 Chlorpheniramine Maleate (Anti-Histaminic) | 64 L - - 19 Dexamethasone (Glucocorticoid) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 06/16/2015; address is 389 Xin Yang Rd. , Yunnun, CHINA, verified against its source on 2026-09-16.
- Firm
- Yunnun Druos Works verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- CHINA verified
- Address
- 389 Xin Yang Rd. , Yunnun, CHINA verified
- Date published
- 06/16/2015 verified
- Product code
- 54 Y - - 04 Ginseng Unconventional Dietary Speciality for Humans or Animals | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 61 X - - 08 Chlorpheniramine Maleate (Anti-Histaminic) | 64 L - - 19 Dexamethasone (Glucocorticoid) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules | Ginseng She Lian Wan Capsules each item verified
- FDA notes
- The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. | The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. | The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. | The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. | The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. each item verified
What the source says
Yunnun Druos Works Date Published : 06/16/2015 389 Xin Yang Rd. , Yunnun, CHINA 54 Y - - 04 Ginseng Unconventional Dietary Speciality for Humans or Animals Date Published: 06/16/2015 Desc: Ginseng She Lian Wan Capsules Notes: The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 06/16/2015 Desc: Ginseng She Lian Wan Capsules Notes: The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. 61 X - - 08 Chlorpheniramine Maleate (Anti-Histaminic) Date Published: 06/16/2015 Desc: Ginseng She Lian Wan Capsules Notes: The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. 64 L - - 19 Dexamethasone (Glucocorticoid) Date Published: 06/16/2015 Desc: Ginseng She Lian Wan Capsules Notes: The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 06/16/2015 Desc: Ginseng She Lian Wan Capsules Notes: The aforementioned product appears to be an unapproved new drug as FDA analysis found undeclared chlorpheniramine and dexamethasone in the product. In addition; the aforementioned product appears to be an unapproved new drug as the product label implies the product is intended for use in the diagnosis; cure; mitigation; treatment; or prevention of disease. Examples of the product's intended use from the product label include but are not limited to the following; 'INDICATIONS; Traditionally use for lumbago; gout; arthrodynia; myasthenia; limb numbness; pains induced by acclimation fever and rheumatism; osteocope and arthritis'.
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.